175 related articles for article (PubMed ID: 1662831)
1. [Possibilities of the cytological method in the determination of therapeutic pathomorphosis of breast cancer].
Sidorova NA; Volchenko NN; Saribekian EK
Sov Med; 1991; (11):15-8. PubMed ID: 1662831
[TBL] [Abstract][Full Text] [Related]
2. [Chemotherapeutic pathomorphosis of breast cancer].
Frank GA; Volchenko NN; Borisov VI
Sov Med; 1990; (11):14-6. PubMed ID: 1963707
[TBL] [Abstract][Full Text] [Related]
3. [The immediate results of the combined treatment of stage-III breast cancer].
Muratkhodzhaev NK; Letiagin VP; Khodzhaev AV
Vopr Onkol; 1990; 36(10):1227-31. PubMed ID: 2174591
[TBL] [Abstract][Full Text] [Related]
4. Integrative tumor board: recurrent breast cancer or new primary? Radiation oncology.
Hirsch A
Integr Cancer Ther; 2003 Sep; 2(3):272-6. PubMed ID: 15035891
[No Abstract] [Full Text] [Related]
5. [Evaluation of the role of radical mastectomy, postoperative radiation and chemotherapy in stage IIb (TI-2NIMO) breast cancer].
Demidov VP; Stranadko EF; Bazhenova AP; Volkova MA; Starinskiĭ VV
Vopr Onkol; 1983; 29(9):85-91. PubMed ID: 6314663
[TBL] [Abstract][Full Text] [Related]
6. Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer.
Danforth DN; Lippman ME; McDonald H; Bader J; Egan E; Lampert M; Steinberg SM; Swain SM
Am Surg; 1990 Jan; 56(1):6-11. PubMed ID: 2153011
[TBL] [Abstract][Full Text] [Related]
7. [Comparative analysis of combined and complex methods of the treatment of stage IIIb breast cancer].
Demidov VP; Borisov VI; Ivanov OA
Vopr Onkol; 1990; 36(12):1473-9. PubMed ID: 2288126
[TBL] [Abstract][Full Text] [Related]
8. Clinical trials referral resource. High priority trials--III. Breast cancer.
Cheson BD; Ungerleider RS
Oncology (Williston Park); 1992 Dec; 6(12):46-50. PubMed ID: 1334690
[No Abstract] [Full Text] [Related]
9. [Treatment of stage I-IIA breast cancer of medial-central localization].
Datsenko VS
Khirurgiia (Mosk); 1998; (11):35-7. PubMed ID: 9864983
[TBL] [Abstract][Full Text] [Related]
10. [Degree of manifestation of therapeutic pathomorphosis and the nature of the change in the estrogen and progesterone receptors after the radiation and chemotherapy of breast cancer].
Ermilova VD; Koposova TL; Murav'ëva NI; Kuz'mina ZV
Vopr Onkol; 1985; 31(12):69-73. PubMed ID: 4082510
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of in situ ductal cancers of the breast].
Rochet Y
Rev Fr Gynecol Obstet; 1991 Nov; 86(11):666-8. PubMed ID: 1664138
[TBL] [Abstract][Full Text] [Related]
12. [Tumor recurrence in the salvaged breast; a second chance?].
Roukema JA; Dolman A; Maat B
Ned Tijdschr Geneeskd; 1989 Dec; 133(52):2593-5. PubMed ID: 2558321
[No Abstract] [Full Text] [Related]
13. Ductal carcinoma in situ (DCIS). A highly treatable breast cancer.
Mayo Clin Womens Healthsource; 2009 Oct; 13(10):1-2. PubMed ID: 19727033
[No Abstract] [Full Text] [Related]
14. [Simultaneous radiochemotherapy in locoregional recurrent breast carcinoma after mastectomy. Results in patients with macroscopic residual tumor R2].
Renner H; van Kampen M
Strahlenther Onkol; 1994 Aug; 170(8):441-52. PubMed ID: 8085210
[TBL] [Abstract][Full Text] [Related]
15. [Preoperative intensive chemotherapy of operable breast cancer].
Zhang B
Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):228-30. PubMed ID: 2558871
[TBL] [Abstract][Full Text] [Related]
16. Integrative tumor board: recurrent breast cancer or new primary? Case Presentation.
Schmaltz J
Integr Cancer Ther; 2003 Sep; 2(3):268-70. PubMed ID: 15035889
[No Abstract] [Full Text] [Related]
17. [Difficulties and errors in the cytological diagnosis of breast cancer].
Kliukina LB; Buglova SE
Vopr Onkol; 1981; 27(12):14-9. PubMed ID: 6275606
[TBL] [Abstract][Full Text] [Related]
18. Integrative tumor board: recurrent breast cancer or new primary? Naturopathic medicine.
Fulop JA
Integr Cancer Ther; 2003 Sep; 2(3):276-83. PubMed ID: 15035892
[No Abstract] [Full Text] [Related]
19. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
Cance WG; Carey LA; Calvo BF; Sartor C; Sawyer L; Moore DT; Rosenman J; Ollila DW; Graham M
Ann Surg; 2002 Sep; 236(3):295-302; discussion 302-3. PubMed ID: 12192316
[TBL] [Abstract][Full Text] [Related]
20. Integrative tumor board: recurrent breast cancer or new primary? Medical oncology.
Boyd DB
Integr Cancer Ther; 2003 Sep; 2(3):270-2. PubMed ID: 15035890
[No Abstract] [Full Text] [Related]
[Next] [New Search]
